GEVO INC (GEVO)

US3743964062 - Common Stock

0.7237  +0.01 (+1.12%)

After market: 0.7125 -0.01 (-1.55%)

Fundamental Rating

2

GEVO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 213 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of GEVO is average, but there are quite some concerns on its profitability. GEVO is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

GEVO had negative earnings in the past year.
In the past year GEVO has reported a negative cash flow from operations.
GEVO had negative earnings in each of the past 5 years.
In the past 5 years GEVO always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -10.18%, GEVO is not doing good in the industry: 91.08% of the companies in the same industry are doing better.
With a Return On Equity value of -11.88%, GEVO is not doing good in the industry: 84.98% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -10.18%
ROE -11.88%
ROIC N/A
ROA(3y)-11.11%
ROA(5y)-18.09%
ROE(3y)-12.96%
ROE(5y)-21.17%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

GEVO's Gross Margin of 6.80% is on the low side compared to the rest of the industry. GEVO is outperformed by 79.34% of its industry peers.
GEVO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

GEVO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GEVO has been increased compared to 1 year ago.
Compared to 5 years ago, GEVO has more shares outstanding
Compared to 1 year ago, GEVO has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.28, we must say that GEVO is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.28, GEVO is not doing good in the industry: 75.12% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.00 indicates that GEVO is not too dependend on debt financing.
GEVO has a better Debt to Equity ratio (0.00) than 82.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.28
ROIC/WACCN/A
WACC6.91%

2.3 Liquidity

A Current Ratio of 4.23 indicates that GEVO has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.23, GEVO belongs to the top of the industry, outperforming 87.32% of the companies in the same industry.
GEVO has a Quick Ratio of 4.18. This indicates that GEVO is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of GEVO (4.18) is better than 87.79% of its industry peers.
Industry RankSector Rank
Current Ratio 4.23
Quick Ratio 4.18

5

3. Growth

3.1 Past

GEVO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.36%, which is quite impressive.
The Revenue has grown by 1357.80% in the past year. This is a very strong growth!
Measured over the past years, GEVO shows a very negative growth in Revenue. The Revenue has been decreasing by -12.14% on average per year.
EPS 1Y (TTM)36.36%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q27.27%
Revenue 1Y (TTM)1357.8%
Revenue growth 3Y45.88%
Revenue growth 5Y-12.14%
Revenue growth Q2Q695.27%

3.2 Future

GEVO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.76% yearly.
The Revenue is expected to grow by 65.72% on average over the next years. This is a very strong growth
EPS Next Y-9.29%
EPS Next 2Y-19.04%
EPS Next 3Y8.69%
EPS Next 5Y46.76%
Revenue Next Year14.98%
Revenue Next 2Y24.94%
Revenue Next 3Y103.27%
Revenue Next 5Y65.72%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GEVO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GEVO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-19.04%
EPS Next 3Y8.69%

0

5. Dividend

5.1 Amount

GEVO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GEVO INC

NASDAQ:GEVO (5/13/2024, 7:00:02 PM)

After market: 0.7125 -0.01 (-1.55%)

0.7237

+0.01 (+1.12%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap174.98M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.18%
ROE -11.88%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 6.8%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.23
Quick Ratio 4.18
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)36.36%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-9.29%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)1357.8%
Revenue growth 3Y45.88%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y